These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7646843)

  • 1. Angiotensin converting enzyme inhibitors and endothelial dysfunction.
    Carretaro OA
    Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 4. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
    Anderson T
    Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level.
    Jiang JL; Zhu HQ; Chen Z; Xu HY; Li YJ
    Int J Cardiol; 2005 May; 101(1):153-5. PubMed ID: 15860402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and the endothelium.
    Hsueh WA; Lyon CJ; Quiñones MJ
    Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of endothelial enzymes: new therapeutic targets.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S100-3. PubMed ID: 11986905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic strategies in the treatment of endothelial dysfunction: facts and outlook].
    Puddu P
    Ital Heart J Suppl; 2000 Feb; 1(2):212-21. PubMed ID: 10731378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of ET-1-induced endothelial dysfunction.
    Iglarz M; Clozel M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):621-8. PubMed ID: 18091577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial function, nitrate derivatives and cardiac insufficiency].
    Ledda F
    G Ital Cardiol; 1996 Sep; 26(9):1067-72. PubMed ID: 9036047
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
    Vogel R
    Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing endothelial dysfunction with ACE inhibitors. A new trend.
    Rajagopalan S; Harrison DG
    Circulation; 1996 Aug; 94(3):240-3. PubMed ID: 8759059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.